The important announcements for Hong Kong stocks yesterday are as follows:

Results Express

$CTG DUTY-FREE (01880.HK)$Earnings Report: Total revenue for the first quarter was about 18.807 billion yuan, a year-on-year decrease of 9.45%; net profit was 2.308 billion yuan, up 0.33% year-on-year.

During the period, the gross margin of the company's main business was 32.70%, an increase of 3.95 percentage points over the same period last year.

$CHENMING PAPER (01812.HK)$Expected net profit of 50 million to 70 million yuan for the first quarter

Operational data

$Q TECH (01478.HK)$: In March, sales of mobile phone camera modules were about 36.839 million units, up 31.8% from the previous month, down 1.7% from the previous year; the total number of camera modules sold was 37.926 million, an increase of 32.2% over the previous year, similar to the previous year. The total sales volume of fingerprint recognition modules was 8.866 million units, an increase of 63.9% over the previous year and a decrease of 4.5% over the previous year.

Sales of camera and fingerprint recognition module products increased month-on-month, mainly due to seasonal recovery after the Spring Festival holiday and customer project cycle factors. The number of camera module sales in other fields increased sharply year over year, mainly due to the good development of the automotive and IoT businesses.

$CHINA LONGYUAN (00916.HK)$: In the first 3 months, a total of 21.225 million megawatt-hours of power generation was completed, an increase of 8.27% over the previous year. Among them, wind power grew by 1.37%, thermal power increased by 11.30%, and other renewable energy sources increased by 233.33%.

$GAC GROUP (02238.HK)$: The cumulative sales volume for the first 3 months was 409,700 units, and the March sales volume was 179,300 units.

$CENTRALCHINA MT (09982.HK)$: In the first 3 months, the total contract sales of projects under management were 3.795 billion yuan, a year-on-year decrease of 26.8%.

$POLY PROPERTY (00119.HK)$: In the first 3 months, cumulative contract sales were 10.8 billion yuan, a year-on-year decrease of 50.23%.

$HOPSON DEV HOLD (00754.HK)$: In the first 3 months, cumulative contract sales amounted to 3.894 billion yuan, a year-on-year decrease of 61.32%.

$POWERLONG (01238.HK)$: In the first 3 months, cumulative contract sales amounted to 3.847 billion yuan, a year-on-year decrease of 56.47%.

$JOY CITY PPT (00207.HK)$: An additional 420 million yuan successfully bid for land use rights for a plot of land in Xi'an.

Pharmaceutical Innovation

$BOAN BIOTECH (06955.HK)$: Abbasip intraocular injection solution (BA9101) developed by the company has completed clinical trials in China and plans to submit a marketing application. It is mainly used to treat pathological neovascularization eye diseases of the retina and choroid.

$CLOVER BIO-B (02197.HK)$: The first batch of young adults in the SCB-1019 phase I clinical trial of the bivalent RSV vaccine candidate received positive preliminary data.

$GENSCRIPT BIO (01548.HK)$：$Legend Biotech (LEGN.US)$It was announced that the US FDA approved CARVYKTI for second-line treatment of patients with recurrent or refractory multiple myeloma.

$FOSUN PHARMA (02196.HK)$: The drug registration application for Dilarose granules and Tirarosil tablets was accepted.

$SHANDONG XINHUA (00719.HK)$: Obtain an approval notice for the supplementation application for paramivir injections.

Investment and operation

$CHINFMINING (01258.HK)$At a discount of approximately 13.54%, it is proposed to place a total of up to 163 million shares, with a net raise of approximately HK$972 million.

$CHALCO (02600.HK)$: Gradually increase the annual cash dividend ratio to no less than 30% of the distributable profit achieved in the current year.

$DATANG RENEW (01798.HK)$It is planned to increase the capital of Danzhou in Datang by 1,755 billion yuan.

Buyback News

$TENCENT (00700.HK)$: It spent approximately HK$1,003 billion to repurchase 3.27 million shares at a repurchase price of HK$304.6 - HK$310.4.

$MEITUAN-W (03690.HK)$: Approximately HK$453 million was spent to repurchase 4,568,200 shares at a repurchase price of HK$97.55-100.6.

$HSBC HOLDINGS (00005.HK)$: Approximately HK$295 million was spent to repurchase 4.7 million shares at a repurchase price of HK$62.55 to HK$62.95.

$XIAOMI-W (01810.HK)$: Spend HK$464.414 million to repurchase 3 million shares at a repurchase price of HK$15.42-HK$15.5.

$KUAISHOU-W (01024.HK)$: Approximately HK$23.131,400 was spent to repurchase 467,300 shares at a repurchase price of HK$48.95 - HK$496.

$SWIRE PACIFIC A (00019.HK)$: A repurchase of 312,500 shares was spent at HK$20088,000, at a repurchase price of HK$63.75 to HK$65.

edit/new